Hep C Flashcards

1
Q

Hepatitis C
Transmission?
Potential for chronic infection?
Curable?

A

Transmission?
- Percutaneous, sexual MSM in HIV+

Potential for chronic infection?
- Yes

Curable?
- Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most frequent mode of transmission in north America?
Which provinces in Canada are the highest risk

A

Sharing IV equipment

Manitoba and Saskatchewan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who should get tested for Hep C

A
  • Every adult should be screened at least once in their lifetime
  • Every pregnant patient: at each pregnancy
  • Everyone with risk factors: screen regularly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F you can acquire HCV from contaminated objects

A

True
- HCV can remain infectious for up to 6 weeks ex-vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do we test for HCV?

A
  1. Anti-HCV test. (antibody)
    - Negative = no infection
    - Positive = have or had HCV
  2. HCV RNA test (if positive)
    - Positive: current infection
    - Negative: past infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T/F We have to test for genotypes in HCV to guide treatment

A

False
- only do it for patients with Hep C who have tried treatment before
OR have cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Who qualifies for HCV treatment

A

Everyone with acute or chronic infection unless palliative or do not want

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are treatment goals for Hep C

A
  • Prevent cirrhosis
  • Prevent HCC (Hepatocellular Carcinoma)
  • Achieve SVR (sustained virologic response = cure) (done 12 weeks after treatment)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do the 3 following HCV treatment class target/ responsible for?
What suffix is their drugs?
N53/4A protease
NS5B polymerase
NS5A

A

N53/4A protease
- target HCV protein processing
- responsible for translation and polyprotein
-PREVIR

NS5B
- target HCV replication
- interacts with several cellular proteins and may be involved in RNA binding
-BUVIR

NS5A
- target HCV replication
- responsible for RNA synthesis
-ASVIR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the treatment duration of HCV

A

8-24 weeks
- Duration depends on presence of cirrhosis, HCV genotype, HCV RNA level

if patient has baseline resistance-associated substitutions or cirrhosis
- include weight-based ribavirin or
- extend DAA Tx duration, urgency increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What pre-treatment workup do you have to do for Hep C management

A
  • CBC count
  • Basic metabolic panel (lytes, creatinine)
  • Hepatic function panel
  • INR
  • HCV RNA
  • HCV test
  • Fibrosis test (fibroscan)
  • HIV, HAV, HBV test
  • Physical exam (ascites)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When do we provide ON treatment monitoring?
What do we do?

A

For patients with decompensated cirrhosis
- CBC
- Hepatic function panel
- HCV RNA PCR

repeat yearly for on-going patients with risk factors for HCV re-infection
or
if they have elevated ALT, AST, or bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What 3 non-invasive tests do we use for liver fibrosis

A
  • Aspartate transaminase to platelet ratio
    (AST: platelet) (APRI)
  • Fibrosis index (FIB-4)
  • Fibroscan (ultrasound)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do the fibroscan results mean?
F0- F4

A

F0: No scarring
F1: MILD fibrosis
F2: MODERATE fibrosis
F3: SEVERE fibrosis
F4: Cirrhosis or advanced fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is baseline Hep B testing screening necessary

A

Hep C treatment can cause Hep B flare up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is are the 2 treatments available for Hep C?
Drug composition
Duration
Food?
DDI?
Contraindication?

A

Maviret
(GlecaPREVIR 300mg/ pibrentASVIR 120mg)
(NS3+4a protease inhibitor/NS5A)
3 tabs daily for 8 weeks
Take with Food
DDI: Ethinyl estradiol (increases ALT), phenytoin, st johns wart, warfarin, statins, etc..
Contraindication: AVOID in decompensated cirrhosis

Epclusa
(SofosBUVIR 400mg/velpatASVIR 100mg)
(NS5B polymerase/NS5A)
1 tab daily for 12 weeks
DDI: PPI, Amiodarone

17
Q

What is the treatment of HEP C after they have had previous treatment and failed?

A

Vosevi
(VoxilaPREVIR/ sofosBUVIR / velpatASVIR )

Presence of resistance mutations did not affect SVR12

SE Diarrhea, headache, fatigue

18
Q

What to look for in cirrhotic HCV patients (3)

A

Determine if current/past decompensation

Calculate child-pugh score (watch for 7+)

Calculate MELD (watch for 19+)

19
Q

What is the treatment for COMPENSATED cirrhosis

A

Same as 1st line options
(Maviret)

If considering Epclusa
- want to check for genotype 3. Causes more complexity

20
Q

What is the treatment for DECOMPENSATED cirrhosis
Dose?
Duration?
ADR?

What is used in Canada?

A

ADD Ribavirin to Epclusa FOR 12 WEEKS
Weight-based dosing:
- <75kg: 1000mg/day
- 75+ kg: 1200mg/day

ADR
- ANEMIA,
- fatigue, neutropenia, insomnia, headache, nausea
PREGNANCY TEST (May cause fetal death & abnormalities in animals)

Do NOT use PIs. (cannot use maviret)

In Canada
- EXTEND EPCLUSA duration to 24 WEEKS.
Note: Ribavirin is discontinued in Canada

21
Q

When do you consider postponing antiviral therapy after liver transplat

A

MELD 25+
- If you treat patients and they improve - they will get bumped down the liver transplant list